publication date: Jun. 12, 2015

21st Century Cures Heads for House Floor Vote

 

The 21st Century Cures Act cleared the House Committee on Energy & Commerce and is heading for floor vote.

The legislation, H.R. 6, is designed to expedite drug development, modernize clinical trials, and accelerate approval of drugs and medical devices. Capitol Hill insiders say the floor vote may occur within two weeks.

Energy and Commerce passed the bill May 21 unanimously, by a 51 to 0 vote. The bill would allocate $10 billion in mandatory funding in new funds to NIH over five years. Another $550 million would go to FDA over the same period.

If the 309-page bill is enacted, funds could start to flow in fiscal 2016.

A parallel measure, called Innovation for Healthier Americans, is moving through the Senate Health, Education, Labor and Pensions Committee.

“Key provisions of this legislation pave the way for critically ill patients to have access to better drugs and treatments,” Rep. Fred Upton (R-Mich.), chair of the committee, said in a statement May 21. “This historic day marks a big bipartisan step forward on our path to cures.”

The legislation is spearheaded by Upton, Oversight and Investigations Subcommittee Ranking Member Diana DeGette (D-Colo.), full committee Ranking Member Frank Pallone Jr. (D-N.J.), Health Subcommittee Chairman Joe Pitts (R-Penn.), and Health Subcommittee Ranking Member Gene Green (D-Texas).

“ASCO applauds the bipartisan efforts that led to the completion of this legislative package, especially … Continue reading 41-23 21st Century Cures Heads for House Floor Vote

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.